One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Rapid drug access and scientific rigour: a delicate balance
doi : 10.1016/S1474-4422(20)30452-X
Volume 20, Issue 1, January 2021, Page 1
Important advances in stroke research in 2020
Georgios Tsivgoulis, Aristeidis H Katsanos
doi : 10.1016/S1474-4422(20)30431-2
Volume 20, Issue 1, January 2021, Pages 2-3
Dementia research in 2020: moving forward despite the COVID-19 pandemic
Miia Kivipelto, Francesca Mangialasche
doi : 10.1016/S1474-4422(20)30453-1
Volume 20, Issue 1, January 2021, Pages 3-5
Advances in traumatic brain injury research in 2020
Danielle K Sandsmark, Ramon Diaz-Arrastia
doi : 10.1016/S1474-4422(20)30455-5
Volume 20, Issue 1, January 2021, Pages 5-7
Headache research in 2020: disrupting and improving practice
Peter J Goadsby
doi : 10.1016/S1474-4422(20)30457-9
Volume 20, Issue 1, January 2021, Pages 7-8
Epilepsy in 2020—a new dawn
J Helen Cross
doi : 10.1016/S1474-4422(20)30438-5
Volume 20, Issue 1, January 2021, Pages 8-10
Movement disorders in 2020: clinical trials, genetic discoveries, and COVID-19
Eng-King Tan
doi : 10.1016/S1474-4422(20)30448-8
Volume 20, Issue 1, January 2021, Pages 10-12
Multiple sclerosis in 2020: un bon cru
Elisabeth Maillart, Catherine Lubetzki
doi : 10.1016/S1474-4422(20)30441-5
Volume 20, Issue 1, January 2021, Pages 12-13
Major advances in amyotrophic lateral sclerosis in 2020
Orla Hardiman
doi : 10.1016/S1474-4422(20)30447-6
Volume 20, Issue 1, January 2021, Pages 14-15
Sleep research in 2020: COVID-19-related sleep disorders
Markku Partinen
doi : 10.1016/S1474-4422(20)30456-7
Volume 20, Issue 1, January 2021, Pages 15-17
Neurological infections in 2020: COVID-19 takes centre stage
Sarah Fredrich, Benjamin M Greenberg, Kimmo J Hatanpaa
doi : 10.1016/S1474-4422(20)30451-8
Volume 20, Issue 1, January 2021, Pages 17-18
Oral steroids for episodic cluster headache
Anne Ducros
doi : 10.1016/S1474-4422(20)30402-6
Volume 20, Issue 1, January 2021, Pages 19-20
Are drugs for multiple sclerosis fatigue just placebos?
Dennis Bourdette
doi : 10.1016/S1474-4422(20)30415-4
Volume 20, Issue 1, January 2021, Pages 20-21
Patisiran in hereditary transthyretin-mediated amyloidosis
Marco Luigetti, Serenella Servidei
doi : 10.1016/S1474-4422(20)30397-5
Volume 20, Issue 1, January 2021, Pages 21-23
Correction to Lancet Neurol 2020; 19: 998–1009
doi : 10.1016/S1474-4422(20)30437-3
Volume 20, Issue 1, January 2021, Page e1
Jacqueline Palace: a force for good in neuroimmune disorders
Jules Morgan
doi : 10.1016/S1474-4422(20)30443-9
Volume 20, Issue 1, January 2021, Page 24
A museum for Cajal's Legacy
Javier DeFelipe, Juan A De Carlos, Arpan R Mehta
doi : 10.1016/S1474-4422(20)30444-0
Volume 20, Issue 1, January 2021, Page 25
Our health-care system is failing young people with epilepsy
Dougal Hargreaves, Jane Hanna, Zachary M Grinspan, Colin Dunkley, ... Helen Cross
doi : 10.1016/S1474-4422(20)30436-1
Volume 20, Issue 1, January 2021, Pages 26-27
Turning the tables on his audience
Peter Ranscombe
doi : 10.1016/S1474-4422(19)30351-5
Volume 20, Issue 1, January 2021, Page 27
The STAGES of life with young onset Parkinson's disease
Clare Sansom
doi : 10.1016/S1474-4422(20)30106-X
Volume 20, Issue 1, January 2021, Page 28
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial
Mark Obermann, Steffen N?gel, Claudia Ose, Nilüfer Sonuc, ... Dagny Holle
doi : 10.1016/S1474-4422(20)30363-X
Volume 20, Issue 1, January 2021, Pages 29-37
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
Bardia Nourbakhsh, Nisha Revirajan, Bridget Morris, Christian Cordano, ... Emmanuelle Waubant
doi : 10.1016/S1474-4422(20)30354-9
Volume 20, Issue 1, January 2021, Pages 38-48
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
David Adams, Michael Polydefkis, Alejandra Gonz?lez-Duarte, Jonas Wixner, ... Thi Hoa (Therese) Do
doi : 10.1016/S1474-4422(20)30368-9
Volume 20, Issue 1, January 2021, Pages 49-59
New therapies for neuromyelitis optica spectrum disorder
Michael Levy, Kazuo Fujihara, Jacqueline Palace
doi : 10.1016/S1474-4422(20)30392-6
Volume 20, Issue 1, January 2021, Pages 60-67
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
Alberto Serrano-Pozo, Sudeshna Das, Bradley T Hyman
doi : 10.1016/S1474-4422(20)30412-9
Volume 20, Issue 1, January 2021, Pages 68-80
